18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study

被引:55
作者
Cassou-Mounat, Thibaut [1 ,2 ,3 ]
Balogova, Sona [1 ,4 ,5 ]
Nataf, Valerie [1 ,6 ]
Calzada, Marie [1 ,2 ]
Huchet, Virginie [1 ]
Kerrou, Khaldoun [1 ]
Devaux, Jean-Yves [2 ,3 ]
Mohty, Mohamad [3 ,7 ,8 ]
Talbot, Jean-Noel [1 ,3 ]
Garderet, Laurent [3 ,7 ,8 ]
机构
[1] Hop Tenon, AP HP, Dept Nucl Med, 4 Rue Chine, F-75020 Paris, France
[2] Hop St Antoine, AP HP, Dept Nucl Med, 184 Rue Fg St Antoine, F-75012 Paris, France
[3] Univ Paris 06, Paris, France
[4] Comenius Univ, Dept Nucl Med, Bratislava, Slovakia
[5] St Elisabeth Oncol Inst, Bratislava, Slovakia
[6] Hop Tenon, AP HP, Radiopharm, 4 Rue Chine, F-75020 Paris, France
[7] INSERM, UMR S Proliferat & Differentiat Stem Cells 938, F-75012 Paris, France
[8] Hop St Antoine, AP HP, Dept Hematol & Therapie Cellulaire, 184 Rue Fg St Antoine, F-75012 Paris, France
关键词
Multiple myeloma; FDG; Fluorocholine (18F) FCH; PET/CT; POSITRON-EMISSION-TOMOGRAPHY; HEPATOCELLULAR-CARCINOMA; C-11-METHIONINE PET/CT; BONE-MARROW; FDG-PET; F-18-FDG; DISEASE; MRI; C-11-ACETATE; DIAGNOSIS;
D O I
10.1007/s00259-016-3392-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Hybrid positron emission tomography/computed tomography (PET/CT) has now become available, as well as whole-body, low-dose multidetector row computed tomography (MDCT) or magnetic resonance imaging (MRI). The radioactive glucose analogue 18F-fluorodeoxyglucose (FDG) is the most widely used tracer but has a relatively low sensitivity in detecting multiple myeloma (MM). We compared FDG with a more recent metabolic tracer, 18F-fluorocholine (FCH), for the detection of MM lesions at time of disease relapse or progression. We analyzed the results of FDG and FCH imaging in 21 MM patients undergoing PET/CT for suspected relapsing or progressive MM. For each patient and each tracer, an on-site reader and a masked reader independently determined the number of intraosseous and extraosseous foci of tracer and the intensity of uptake as measured by their SUVmax and the corresponding target/non-target ratio (T/NT). In the skeleton of 21 patients, no foci were found for two cases, uncountable foci were observed in four patients, including some mismatched FCH/FDG foci. In the 15 patients with countable bone foci, the on-site reader detected 72 FDG foci vs. 127 FCH foci (+76 %), whereas the masked reader detected 69 FDG foci vs. 121 FCH foci (+75 %), both differences being significant. Interobserver agreement on the total number of bone foci was very high, with a kappa coefficient of 0.81 for FDG and 0.89 for FCH. Measurement of uptake in the matched foci that took up both tracers revealed a significantly higher median SUVmax and T/NT for FCH vs. FDG. Almost all unmatched foci were FCH-positive FDG-negative (57/59 = 97 % on-site and 56/60 = 93 % on masked reading); they were more frequently observed than matched foci in the head and neck region. These findings suggest that PET/CT performed for suspected relapsing or progressive MM would reveal more lesions when using FCH rather than FDG.
引用
收藏
页码:1995 / 2004
页数:10
相关论文
共 37 条
  • [1] Extent of Disease Burden Determined With Magnetic Resonance Imaging of the Bone Marrow Is Predictive of Survival Outcome in Patients With Multiple Myeloma
    Ailawadhi, Sikander
    Abdelhalim, Ahmed N.
    Derby, Lyudmyla
    Mashtare, Terry L.
    Miller, Kena C.
    Wilding, Gregory E.
    Alberico, Ronald A.
    Gottlieb, Ronald
    Klippenstein, Donald L.
    Lee, Kelvin
    Chanan-Khan, Asher A.
    [J]. CANCER, 2010, 116 (01) : 84 - 92
  • [2] Multiple Myeloma
    Anderson, Kenneth C.
    Alsina, Melissa
    Bensinger, William
    Biermann, Sybil
    Chanan-Khan, Asher
    Cohen, Adam D.
    Devine, Steven
    Djulbegovic, Benjamin
    Gasparetto, Cristina
    Huff, Carol Ann
    Jagasia, Madan
    Medeiros, Bruno C.
    Meredith, Ruby
    Raje, Noopur
    Schriber, Jeffrey
    Singhal, Seema
    Somlo, George
    Stockerl-Goldstein, Keith
    Tricot, Guido
    Vose, Julie M.
    Weber, Donna
    Yahalom, Joachim
    Yunus, Furhan
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (09): : 908 - 942
  • [3] F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
    Bartel, Twyla B.
    Haessler, Jeff
    Brown, Tracy L. Y.
    Shaughnessy, John D., Jr.
    van Rhee, Frits
    Anaissie, Elias
    Alpe, Terri
    Angtuaco, Edgardo
    Walker, Ronald
    Epstein, Joshua
    Crowley, John
    Barlogie, Bart
    [J]. BLOOD, 2009, 114 (10) : 2068 - 2076
  • [4] FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
    Boellaard, Ronald
    O'Doherty, Mike J.
    Weber, Wolfgang A.
    Mottaghy, Felix M.
    Lonsdale, Markus N.
    Stroobants, Sigrid G.
    Oyen, Wim J. G.
    Kotzerke, Joerg
    Hoekstra, Otto S.
    Pruim, Jan
    Marsden, Paul K.
    Tatsch, Klaus
    Hoekstra, Corneline J.
    Visser, Eric P.
    Arends, Bertjan
    Verzijlbergen, Fred J.
    Zijlstra, Josee M.
    Comans, Emile F. I.
    Lammertsma, Adriaan A.
    Paans, Anne M.
    Willemsen, Antoon T.
    Beyer, Thomas
    Bockisch, Andreas
    Schaefer-Prokop, Cornelia
    Delbeke, Dominique
    Baum, Richard P.
    Chiti, Arturo
    Krause, Bernd J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (01) : 181 - 200
  • [5] Value of FDG PET in the assessment of patients with multiple myeloma
    Bredella, MA
    Steinbach, L
    Caputo, G
    Segall, G
    Hawkins, R
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (04) : 1199 - 1204
  • [6] Calabria F, 2014, CLIN NUCL MED, V39, P122, DOI 10.1097/RLU.0000000000000303
  • [7] Lesions of Multiple Myeloma Adjacent to the Skull Are Better Visualized on F-18 Fluoroethyldimethyl-2-Hydroxyethylammonium (FECH) PET Images Than on F-18 FDG PET Images
    Cheng, Xin
    Cui, Ruixue
    Li, Fang
    Zhuang, Hongming
    [J]. CLINICAL NUCLEAR MEDICINE, 2011, 36 (10) : 912 - 914
  • [8] Multiple myeloma:: Molecular imaging with 11C-methionine PET/CT -: Initial experience
    Dankerl, Anja
    Liebisch, Peter
    Glatting, Gerhard
    Friesen, Claudia
    Blumstein, Norbert M.
    Kocot, Darius
    Wendl, Christiane
    Bunjes, Donald
    Reske, Sven N.
    [J]. RADIOLOGY, 2007, 242 (02) : 498 - 508
  • [9] DeGrado TR, 2001, CANCER RES, V61, P110
  • [10] 18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation
    Derlin, Thorsten
    Weber, Christoph
    Habermann, Christian R.
    Herrmann, Jochen
    Wisotzki, Christian
    Ayuk, Francis
    Wolschke, Christine
    Klutmann, Susanne
    Kroeger, Nicolaus
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (03) : 493 - 500